Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2064]
News [3524]
Articles [160]
Editorials [3]
Conferences [127]
elearning [18]

PD-1 enhances elotuzumab efficacy

Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA
PD-1 enhances elotuzumab efficacy ( Dr Natalie Bezman - Bristol-Meyers Squibb, Princeton, USA )
12 Jun 2016

Novel therapies for older patients with AML and MDS

Prof Naval Daver - MD Anderson Cancer Center, Houston, United States
Novel therapies for older patients with AML and MDS ( Prof Naval Daver - MD Anderson Cancer Center, Houston, United States )
12 Jun 2016

Better screening programmes needed for haematological malignancies such as leukaemia

Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany
Better screening programmes needed for haematological malignancies such as leukaemia ( Dr Brigitte Schlegerberger - Hannover Medical School, Hannover, Germany )
12 Jun 2016

Karyotyping a CLL subset with ibrutinib susceptibility

Dr Jeffrey Jones - Ohio State University, Columbus, USA
Karyotyping a CLL subset with ibrutinib susceptibility ( Dr Jeffrey Jones - Ohio State University, Columbus, USA )
12 Jun 2016

Chemo-genomic interrogation reveals JAK sensitive subgroup in AML

Dr Vincent-Philippe Lavallée - Université de Montréal, Montréal, Canada
Chemo-genomic interrogation reveals JAK sensitive subgroup in AML ( Dr Vincent-Philippe Lavallée - Université de Montréal, Montréal, Canada )
12 Jun 2016

The role of AKT in chronic lymphocytic leukaemia transformation to Richter's syndrome

Dr Christian Pallasch, University Hospital of Cologne, Cologne, Germany
The role of AKT in chronic lymphocytic leukaemia transformation to Richter's syndrome ( Dr Christian Pallasch, University Hospital of Cologne, Cologne, Germany )
12 Jun 2016

Advances in first line treatment options for MCL patients

Professor Steven Le Gouill and Professor Simon Rule
Advances in first line treatment options for MCL patients ( Professor Steven Le Gouill and Professor Simon Rule )
11 Jun 2016

Targeted genome editing in haematopoeitic stem cells

Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy
Targeted genome editing in haematopoeitic stem cells ( Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy )
11 Jun 2016

A microRNA driver of B-cell leukaemia

Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy
A microRNA driver of B-cell leukaemia ( Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy )
11 Jun 2016

The latest in CLL from EHA 2016

Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam
The latest in CLL from EHA 2016 ( Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam )
11 Jun 2016

Safety and efficacy of imatinib generics

Prof Tomasz Sacha - Jagiellonian University, Krakow, Poland
Safety and efficacy of imatinib generics ( Prof Tomasz Sacha - Jagiellonian University, Krakow, Poland )
11 Jun 2016

Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo

Dr Amir Fathi, Massachusetts General Hospital, Boston, USA
Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo ( Dr Amir Fathi, Massachusetts General Hospital, Boston, USA )
11 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation